NEURONOPATHIC LYSOSOMAL STORAGE DISEASES: CLINICAL AND PATHOLOGIC FINDINGS

被引:12
|
作者
Prada, Carlos E. [1 ,2 ]
Grabowski, Gregory A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA
[2] Cardiovasc Fdn Colombia, Ctr Genom Med & Metab, Floridablanca, Colombia
关键词
lysosomal storage diseases; neuronopathic disease; autophagy; inflammation; cell death; pathogenesis; NEURONAL CEROID-LIPOFUSCINOSES; ACID MALTASE DEFICIENCY; TAY-SACHS-DISEASE; GLOBOID-CELL LEUKODYSTROPHY; GAUCHER-DISEASE; SANDHOFF-DISEASE; KRABBE-DISEASE; PARKINSON-DISEASE; MOUSE MODEL; NEUROAXONAL DYSTROPHY;
D O I
10.1002/ddrr.1116
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The lysosomal-autophagocytic system diseases (LASDs) affect multiple body systems including the central nervous system (CNS). The progressive CNS pathology has its onset at different ages, leading to neurodegeneration and early death. Methods: Literature review provided insight into the current clinical neurological findings, phenotypic spectrum, and pathogenic mechanisms of LASDs with primary neurological involvement. Conclusions: CNS signs and symptoms are variable and related to the disease-specific underlying pathogenesis. LAS dysfunction leads to diverse global cellular consequences in the CNS ranging from specific axonal and dendritic abnormalities to neuronal death. Pathogenic mechanisms for disease progression vary from impaired autophagy, massive storage, regional involvement, to end-stage inflammation. Some of these features are also found in adult neurodegenerative disorders, for example, Parkinson's and Alzheimer's diseases. Lack of effective therapies is a significant unmet medical need. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:226 / 246
页数:21
相关论文
共 50 条
  • [1] Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
    Jakobkiewicz-Banecka, Joanna
    Gabig-Ciminska, Magdalena
    Banecka-Majkutewicz, Zyta
    Banecki, Bogdan
    Wegrzyn, Alicja
    Wegrzyn, Grzegorz
    METABOLIC BRAIN DISEASE, 2014, 29 (01) : 1 - 8
  • [2] Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
    Joanna Jakóbkiewicz-Banecka
    Magdalena Gabig-Cimińska
    Zyta Banecka-Majkutewicz
    Bogdan Banecki
    Alicja Węgrzyn
    Grzegorz Węgrzyn
    Metabolic Brain Disease, 2014, 29 : 1 - 8
  • [3] ASTROCYTES AND LYSOSOMAL STORAGE DISEASES
    Rao, K. V. Rama
    Kielian, T.
    NEUROSCIENCE, 2016, 323 : 195 - 206
  • [4] Therapeutic approaches for neuronopathic lysosomal storage disorders
    Schiffmann, Raphael
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) : 373 - 379
  • [5] Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases
    Matte, Ursula
    Lagranha, Valeska Lizzi
    de Carvalho, Talita Giacomet
    Mayer, Fabiana Quoos
    Giugliani, Roberto
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (05) : 983 - 990
  • [6] Substrate deprivation therapy:: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases
    Jakobkiewicz-Banecka, Joanna
    Wegrzyn, Alicja
    Wegrzyn, Grzegorz
    JOURNAL OF APPLIED GENETICS, 2007, 48 (04) : 383 - 388
  • [7] Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases
    Joanna Jakóbkiewicz-Banecka
    Alicja Węgrzyn
    Grzegorz Węgrzyn
    Journal of Applied Genetics, 2007, 48 : 383 - 388
  • [8] Editorial: Neuronopathic lysosomal storage diseases-specific neuronal characteristics and therapeutic approaches
    Flunkert, Stefanie
    Hutter-Paier, Birgit
    Sun, Ying
    Kehr, Jan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [9] Skeletal Abnormalities in Lysosomal Storage Diseases
    Stevenson, David A.
    Steiner, Robert D.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 10 : 406 - 416
  • [10] Oncological Aspects of Lysosomal Storage Diseases
    Lugowska, Agnieszka
    CELLS, 2024, 13 (19)